Related by context. Frequent words. (Click for all words.) 76 Swedish Orphan Biovitrum 70 Crucell NV Euronext 69 NASDAQ CRXL 69 Active Biotech AB 69 BioInvent International 65 Merck Serono division 65 Meda AB 64 Exchange CRX 64 Actelion Ltd 64 Janssen Pharmaceutica NV 64 Helsinn 64 PregLem 64 Addex Pharmaceuticals 64 GlaxoSmithKline plc GSK 63 OTCQX RHHBY 63 Archemix Corp. 63 Karo Bio 63 Merck KGaA Darmstadt Germany 62 ALTANA Pharma 62 Inc. Nasdaq IMGN 62 SCHWARZ PHARMA 62 Application MAA 62 NASDAQ SHPGY 62 Exploit collaboration 62 Response Biomedical Corporation 62 NV Organon 62 Evotec AG 62 Bayer HealthCare AG 62 Biovitrum 61 Pharmion Corporation 61 Orexo 61 Nasdaq REGN 61 NASDAQ IMCL 61 Aradigm Corporation 61 Onalta 61 UCB Pharma 60 Cetrorelix 60 ZALBIN 60 Nasdaq VRTX 60 Group NV Pharming 60 Clavis Pharma 60 Ligand Pharmaceuticals Incorporated 60 Inc. Nasdaq HGSI 60 Esprit Pharma 60 Icatibant 60 CTI Nasdaq 60 Merz Pharmaceuticals 60 Idera Pharmaceuticals 60 Nymox Pharmaceutical Corporation 60 Ono Pharmaceutical 60 Jerini AG 60 Phase III Clinical Trial 60 Basilea Pharmaceutica 59 Shire plc LSE SHP 59 Inc Therapeutic Competitors 59 Med AB 59 Application BLA 59 BioSpecifics Technologies Corp. 59 Loramyc ® 59 Progenics Pharmaceuticals 59 LEO Pharma 59 BASF Aktiengesellschaft 59 Tibotec Pharmaceuticals 59 Nautilus Biotech 58 ARYx Therapeutics Inc. 58 Biotest AG 58 Belimumab 58 Kiadis Pharma 58 Norgine 58 Active Biotech 58 Phase III Trial 58 Positive Opinion 58 Amarillo Biosciences Inc. 58 STOCKHOLM Sweden BUSINESS WIRE 58 OncoGenex Pharmaceuticals Inc. 58 LFB Biotechnologies 58 TSX TLN 58 Photocure 58 NASDAQ DYAX 58 Metabasis Therapeutics Inc. 58 FDA Accepts 58 Pronova BioPharma 58 Symphogen 58 GSK Biologicals 58 Debiopharm Group 58 Nippon Kayaku 58 submitted Marketing Authorization 58 Nasdaq BDSI 58 MGI PHARMA INC. 58 Advancing Drugs 58 Santhera 58 EPIX Pharmaceuticals Inc. 58 Jerini 57 Shire plc 57 RegeneRx Biopharmaceuticals Inc. 57 Pirfenidone 57 SCOLR Pharma Inc. 57 Recombinant Human 57 Ranexa R 57 Palatin Technologies Inc. 57 Repligen Corporation